Navigation Links
Ford and Labor Leaders Join Forces with March of Dimes
Date:10/9/2009

"The March of Dimes is a remarkable organization and the outstanding individuals honored tonight are terrific role models for all of us," said Alan Mulally. "On behalf of all Ford Motor Company stakeholders, I am honored to serve alongside Ron Gettelfinger and these outstanding volunteers for the good of healthy babies."

Dr. Jennifer L. Howse, President of the March of Dimes, shared startling statistics showing that nearly 13 million infants were born preterm worldwide in 2005 and more than a million infants die each year from their early birth. The United States' rate of premature birth has increased by 36 percent in the last 25 years and is a significant contributor to rising health care costs.

"The leadership of volunteers enabled the March of Dimes to conquer polio," said Dr. Howse. "We are confident that the team of Gettelfinger and Mulally, along with 3 million volunteers can reduce the toll of premature birth and help lead the way toward a time when every baby in every community is born healthy."

About the March of Dimes

The March of Dimes is the leading nonprofit organization for pregnancy and baby health. Companies and individuals can join the 2010 March for Babies online at www.marchforbabies.org/kickoff2010.

SOURCE March of Dimes


'/>"/>
SOURCE March of Dimes
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Health care incentive model offers collaborative approach
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
4. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
5. Laboratory at UI plays major role in diagnosing cancer
6. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Recovery Resources Collaborates with Two Nonprofit Agencies for Children of Alcoholics Outreach Program
9. MU researchers to collaborate on $20 million project
10. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
11. American Red Cross and FedEx Announce Collaboration to Help Small Businesses Get Prepared for Disaster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... delivered ,, WASHINGTON, Dec. 15 ... that healthcare reform does not override the prostate ... in 37 states. ,, Prostate cancer screening is ... and individuals who are identifiable as high risk, ... a family history of prostate cancer. The American ...
(Date:12/15/2009)... MENLO PARK, Calif., Dec. 15 ... its position in the pharmaceutical and bio-tech ... (Caduceus Marketing Research). Over the past 11 ... panel, the Physicians Consulting Network (PCN®), which ... healthcare professionals covering both primary care and ...
(Date:12/15/2009)... Team In Training (TNT), The Leukemia ... sports training program, has reached a remarkable milestone ... research and patient services. ,, For more than ... endurance sports training program, preparing amateurs and seasoned ... 100-mile century cycle ride or hike adventure. Through ...
(Date:12/15/2009)... NEW YORK, Dec. 15 The following are ... Attorney General for the criminal division, at the ... you, Secretary Sebelius. And thank you for the ... the HEAT initiative. ,, Together, our Departments ... lasting results. ,, We,ve made tremendous progress in ...
(Date:12/15/2009)... Mass., Dec. 15 North American application ... in November year-over-year, according to the MIB ... insurance applications over the past three months have ... levels of -1.6%, to flat at November,s close, ... their interest in the benefits available from life ...
Breaking Medicine News(10 mins):Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... to a long-standing assumption that blood vessel cells in ... a new study unequivocally demonstrates that tumor blood vessel ... Cell Press in the September issue of the journal ... that are atypically stem cell-like and have the potential ...
... coaching pioneer to discuss growing popularity of health coaching, advantages of ... , ... Cincinnati, OH (PRWEB) September 8, 2008 -- Hummingbird ... coaching at the Medical Wellness Forum, scheduled for September 9-11, 2008 ...
... a company established in 2002, will begin to market "Platinum ... of NZymeCeuticals, Inc., announced Friday the company will begin to ... as "PN20K" to North and South America. , ... ...
... appear to lower a man,s PSA level, the blood biomarker ... is at risk of prostate cancer. , But the authors ... journal Cancer , caution that men shouldn,t take the ... , "We showed that men who regularly took certain ...
... in Molecular,Testing and Personalized Medicine, NORTHFIELD, Ill., ... a transformation point. Molecular testing and the promise,of ... treated. Digital,slides and other imaging technologies will change ... is taking a leadership role in,making sure that ...
... how theoretical ,anti-cloak, could bring objects out of hiding ... case someone develops a cloak of invisibility, a team ... the objects it hides. , According to a paper ... an invisibility cloak would allow invisible objects to be ...
Other Medicine News:Health News:Apples and oranges: Tumor blood vessel cells are remarkably atypical 2Health News:Hummingbird Coaching Services to Speak on Wellness Coaching and Positive Psychology at Medical Wellness Forum 2Health News:Hummingbird Coaching Services to Speak on Wellness Coaching and Positive Psychology at Medical Wellness Forum 3Health News:NZymeCeuticals Announces the Introduction of New Bulk Ingredient 'Platinum Nattokinase' (PN20K) to Dietary Supplement Industry 2Health News:Common painkillers lower levels of prostate cancer biomarker 2Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Systemic ... and Market Forecasts to 2015 ... Systemic Lupus Erythematosus - Drug Pipeline ... ,, Summary ,, GlobalData, ...
(Date:12/15/2009)... EnzySurge Ltd.,(EnzySurge), a provider of ... market, announced today that it has received ... (FDA) to market its new,SilverStream(TM) solution for ... Over-the-Counter version of the SilverStream product. , ... developer of the DermaStream(R) product line.,DermaStream is ...
(Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 NxStage Medical, ... of innovative dialysis products, today announced that a ... partners will be embarking on a week-long, conventional ... cyclers. The cruise, dubbed the "2010 Freedom ... from Miami, Fla. on January 3, 2010 and ...
Breaking Medicine Technology:Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4NOAA deploys new smart buoy off Annapolis 10694 1NOAA deploys new smart buoy off Annapolis 10694 2Energy saving powder 10692 1Energy saving powder 10692 2Energy saving powder 10692 3Largest ever database for liver proteins may lead to treatments for hepatitis 10690 1
... Pa., May 14 The Quigley,Corporation (Nasdaq: ... by its wholly owned subsidiary, Quigley Pharma Inc., ... activity of its compound,QR448(a). The compound was administered ... Virus (IBV). The data from the study indicated,that ...
... Host Webcast to Review Data Tuesday, May 13 at 1:00 p.m. EDT ... ... Calif., May 13 /PRNewswire-FirstCall/,-- XTENT, Inc. (Nasdaq: XTNT ) today announced ... safety and,efficacy of the Custom NX(R) drug eluting stent (DES) system for ...
Other Medicine Technology:Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4